Concepedia

Publication | Open Access

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer

DOIFull Paper Access

17

Citations

17

References

2023

Year

David W. Cescon, John Hilton, Serafín Morales, Rachel M. Layman, Timothy Pluard, Belinda Yeo, In Hae Park, Louise Provencher, Sung‐Bae Kim, Young‐Hyuck Im,
Clinical Cancer Research

Abstract

Molibresib in combination with fulvestrant did not demonstrate clinically meaningful activity in this study.

References

YearCitations

Page 1